TRUALT BIOENERGY Q2 : CONS NET PROFIT TURNAROUND AT RS 34.99 CR; H1 PAT RS 94.27 CR VS RS 33.27 CR LOSS (YOY). STRONG (ON 1ST LOOK)

• H1 revenue up 243% at ₹1,437.98 Cr (YOY); Q2 revenue ₹811.10 Cr, up ~606% (YOY). • H1 EBITDA up 532% at ₹233.92 Cr (YOY); margins 16.27% v 8.83% (YOY), up ~744 bps. • Q2 EBITDA ₹101.16 Cr with margin 12.47%; Q2 PAT ₹34.99 Cr. • Caution: higher maize prices moderated Q2 margins; dual-feed covers 1,300 KLPD of 2,000 KLPD installed capacity across 5 Karnataka units. Impact: Sharp earnings turnaround and margin expansion, with maize price inflation a near-term watch item.

TruAlt Bioenergy Limited

Open attachment

← Back to feed